Gfree - For Improved Blood Sugar and Reduced Inflammation.
GFREE - A Study for Improved Blood Sugar Levels, Reduced Inflammation and for Increasing Knowledge of the Connection Between Diabetes and COVID-19.
Göteborg University
60 participants
May 4, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to reduce inflammation and improve glycemic control in healthy volunteers, parents, as well as children, adolescents and adults with or without diabetes. The main questions it aims to answer are: • does a reduction wheat gluten improve glycemic control and/or inflammatory biomarkers • does a reduction in certain amino acids (which is most common in wheat gluten) improve glycemic control and/or inflammatory biomarkers • can we identify individuals with an inflammatory response, which leads to poor glycemic control. Participants will eat gluten-free products as well as similar products containing gluten. They will also eat gluten together with probiotics to see if an effect of gluten can be reduced. Researchers will compare everyone with themselves (cross-over design) and if possible individuals with and without diabetes.
Eligibility
Inclusion Criteria1
- \- none
Exclusion Criteria1
- \- A diagnosis of celiac disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
see info in arm description
see info in arm description
see info in arm description
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05894746